Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
On the steps of cell-to-cell HIV transmission between CD4 T cells.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients.
Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevance.
[Resistance genotyping in patients with therapeutic failure].